1. Home
  2. ALLK vs MGLD Comparison

ALLK vs MGLD Comparison

Compare ALLK & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • MGLD
  • Stock Information
  • Founded
  • ALLK 2012
  • MGLD 1996
  • Country
  • ALLK United States
  • MGLD United States
  • Employees
  • ALLK N/A
  • MGLD N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • MGLD Finance/Investors Services
  • Sector
  • ALLK Health Care
  • MGLD Finance
  • Exchange
  • ALLK Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • ALLK 58.0M
  • MGLD 52.9M
  • IPO Year
  • ALLK 2018
  • MGLD N/A
  • Fundamental
  • Price
  • ALLK $1.16
  • MGLD $1.28
  • Analyst Decision
  • ALLK Hold
  • MGLD
  • Analyst Count
  • ALLK 5
  • MGLD 0
  • Target Price
  • ALLK $1.67
  • MGLD N/A
  • AVG Volume (30 Days)
  • ALLK 1.3M
  • MGLD 2.6K
  • Earning Date
  • ALLK 11-06-2024
  • MGLD 11-26-2024
  • Dividend Yield
  • ALLK N/A
  • MGLD N/A
  • EPS Growth
  • ALLK N/A
  • MGLD N/A
  • EPS
  • ALLK N/A
  • MGLD N/A
  • Revenue
  • ALLK N/A
  • MGLD $32,511,000.00
  • Revenue This Year
  • ALLK N/A
  • MGLD N/A
  • Revenue Next Year
  • ALLK N/A
  • MGLD N/A
  • P/E Ratio
  • ALLK N/A
  • MGLD N/A
  • Revenue Growth
  • ALLK N/A
  • MGLD N/A
  • 52 Week Low
  • ALLK $0.54
  • MGLD $0.78
  • 52 Week High
  • ALLK $3.41
  • MGLD $1.92
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 51.18
  • MGLD 48.86
  • Support Level
  • ALLK $1.29
  • MGLD $1.15
  • Resistance Level
  • ALLK $1.56
  • MGLD $1.47
  • Average True Range (ATR)
  • ALLK 0.14
  • MGLD 0.08
  • MACD
  • ALLK -0.03
  • MGLD 0.01
  • Stochastic Oscillator
  • ALLK 14.89
  • MGLD 47.22

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: